Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

JAK2 Inhibitors Do Not Affect Stem Cells Present in the Spleens of Patients with Myelofibrosis

Xiaoli Wang, MD, PhD, Joseph Tripodi, MS, Jesse Novak, Min Lu, PhD., Yan Li, Vesna Najfeld, Ph.D, Ronald Hoffman, MD

Blood (2012) 120 (21): 1752.

https://doi.org/10.1182/blood.V120.21.1752.1752

Published: 2012

Journal Articles

Jumping Translocations of the Long Arms of Chromosome 1 (1qJT) in Myeloproliferative Neoplasms (MPNs) and Myelodysplastic Syndromes (MDS) Are Associated with High Risk of Transformation to Acute Myelogenous Leukemia (AML).

Vesna Najfeld, Ph.D., Joseph Tripodi, Steven Fruchtman, MD, Lewis R. Silverman, MD, Richard T. Silver, MD, Angela Scalise, Ronald Hoffman, MD

Blood (2009) 114 (22): 1567.

https://doi.org/10.1182/blood.V114.22.1567.1567

Published: 2009

Journal Articles

A Phase I Study of LBH589, a Novel Histone Deacetylase Inhibitor in Patients with Primary Myelofibrosis (PMF) and Post-Polycythemia/Essential Thrombocythemia Myelofibrosis (Post-PV/ET MF).

John Mascarenhas, MD, Xiaoli Wang, MD, PhD, Amelyn Rodriguez, BSN, RN, OCN, Mingjiang Xu, MD, PhD, Elaine Gorman, ANP-BC, Wenyong Zhang, MD, PhD, Judith D. Goldberg, Sc.D., Vesna Najfeld, Ph.D., Ronald Hoffman, MD

Blood (2009) 114 (22): 308.

https://doi.org/10.1182/blood.V114.22.308.308

Published: 2009

Journal Articles

A Multicenter, Open Label Phase I/II Study of CEP701 (Lestaurtinib) in Adults with Myelofibrosis; a Report On Phase I: A Study of the Myeloproliferative Disorders Research Consortium (MPD-RC).

Elizabeth Hexner, MD, Judith D. Goldberg, Sc.D., Josef T. Prchal, MD, Erin P Demakos, RN, Sabina Swierczek, Ph.D., Rona Singer Weinberg, PhD, Joseph Tripodi, M.S., Vesna Najfeld, Ph.D., Martin Carroll, MD, Roberto Marchioli, MD, Lewis R. Silverman, MD, Ronald Hoffman, MD

Blood (2009) 114 (22): 754.

https://doi.org/10.1182/blood.V114.22.754.754

Published: 2009

Journal Articles

The Role of Microtubule Regulatory Protein Stathmin (STMN1) in Megakaryopoiesis.

Camelia Iancu-Rubin, PhD, Joseph Tripodi, Vesna Najfeld, Ph.D., George F. Atweh, MD

Blood (2009) 114 (22): 4591.

https://doi.org/10.1182/blood.V114.22.4591.4591

Published: 2009

Journal Articles

Effects of a Novel Benzyl Styryl Sulfone Derivative ON 01910.Na On the Myelodysplastic Syndrome (MDS) Derived Clone in Patients Relapsing Following Response to Azacitidine (AzaC) Therapy.

Lewis R. Silverman, MD, Rosalie Odchimar-Reissig, Shyamala C. Navada, MD, Takao Ohnuma, MD, Vesna Najfeld, Ph.D., Francois Wilhelm, MD, Ph.D, E. Premkumar Reddy, PhD, James F Holland

Blood (2009) 114 (22): 4839.

https://doi.org/10.1182/blood.V114.22.4839.4839

Published: 2009

Journal Articles

Effective Management of Patients with Leukemic Transformation of Myelofibrosis.

Shyamala C. Navada, MD, John Mascarenhas, MD, Vesna Najfeld, Ph.D., Ronald Hoffman, MD

Blood (2009) 114 (22): 4967.

https://doi.org/10.1182/blood.V114.22.4967.4967

Published: 2009

Journal Articles

The Relationship Between Chromosomally Abnormal Hematopoiesis and the JAK2V617F Allele Burden in Patients (pts) with Ph-Negative Chronic Myeloproliferative Disorders (Ph-neg MPD)

Xialoli Wang, MD, Ph.D., Amanda Leblanc, Steven Gruenstein, MD, Mingjiang Xu, Ph.D., Nathaniel Wisch, MD, Ronald Hoffman, MD, Vesna Najfeld, Ph.D

Blood (2008) 112 (11): 3106.

https://doi.org/10.1182/blood.V112.11.3106.3106

Published: 2008

Journal Articles

Mast Cells Are Involved by the Malignant Process and Play An Important Role in the Pruritogenesis in Patients with Myeloproliferative Disorders

Takefumi Ishii, M.D., Ph.D., Jiapeng Wang, Wei Zhang, John Mascarenhas, M.D., Ying Dai, Vesna Najfeld, Ph.D, Ronald Hoffman, M.D., Nathaniel Wisch, M.D., Mingjiang Xu, M.D., Ph.D.

Blood (2008) 112 (11): 3729.

https://doi.org/10.1182/blood.V112.11.3729.3729

Published: 2008

Journal Articles

Tracking the MDS Clone in Peripheral Blood (PB) Cells from Patients (pts) with Myelodysplastic Syndrome (MDS) Undergoing Azacitidine (AZAC)-Based Therapy.

Amanda Cozza, MSc, Lewis Silverman, M.D., Rosalie Odchimar-Reissig, R.N., Ilene Schulman, R.N, Svetlana Zinzar, Ph.D., Vesna Najfeld, Ph.D.

Blood (2007) 110 (11): 4600.

https://doi.org/10.1182/blood.V110.11.4600.4600

Published: 2007

Journal Articles

The Modulating Effect of Azacitidine (Aza C) on the Cytogenetically Tracked MDS Clone Impact Survival.

Vesna Najfeld, Ph.D., Angela Scalise, B.Sc, Rosalie Odchimer-Reissig, R.N., Lewis R. Silverman, MD

Blood (2004) 104 (11): 1429.

https://doi.org/10.1182/blood.V104.11.1429.1429

Published: 2004

Journal Articles

Pretreatment Cytogenetic Abnormalities in Polycythemia Vera (PV) Determines the Effectivnes of Imatinib : Studies from a Multi-Institutional Trial.

Vesna Najfeld, Ph.D., Richard T. Silver, MD, Ronald Hoffman, MD, August Salvado, MD, Rona Weinberg, Ph.D., Steven Fruchtman, MD

Blood (2004) 104 (11): 2431.

https://doi.org/10.1182/blood.V104.11.2431.2431

Published: 2004

NARROW

JAK2 Inhibitors Do Not Affect Stem Cells Present in the Spleens of Patients with Myelofibrosis

Jumping Translocations of the Long Arms of Chromosome 1 (1qJT) in Myeloproliferative Neoplasms (MPNs) and Myelodysplastic Syndromes (MDS) Are Associated with High Risk of Transformation to Acute Myelogenous Leukemia (AML).

A Phase I Study of LBH589, a Novel Histone Deacetylase Inhibitor in Patients with Primary Myelofibrosis (PMF) and Post-Polycythemia/Essential Thrombocythemia Myelofibrosis (Post-PV/ET MF).

A Multicenter, Open Label Phase I/II Study of CEP701 (Lestaurtinib) in Adults with Myelofibrosis; a Report On Phase I: A Study of the Myeloproliferative Disorders Research Consortium (MPD-RC).

The Role of Microtubule Regulatory Protein Stathmin (STMN1) in Megakaryopoiesis.

Effects of a Novel Benzyl Styryl Sulfone Derivative ON 01910.Na On the Myelodysplastic Syndrome (MDS) Derived Clone in Patients Relapsing Following Response to Azacitidine (AzaC) Therapy.

Effective Management of Patients with Leukemic Transformation of Myelofibrosis.

The Relationship Between Chromosomally Abnormal Hematopoiesis and the JAK2V617F Allele Burden in Patients (pts) with Ph-Negative Chronic Myeloproliferative Disorders (Ph-neg MPD)

Mast Cells Are Involved by the Malignant Process and Play An Important Role in the Pruritogenesis in Patients with Myeloproliferative Disorders

Tracking the MDS Clone in Peripheral Blood (PB) Cells from Patients (pts) with Myelodysplastic Syndrome (MDS) Undergoing Azacitidine (AZAC)-Based Therapy.

The Modulating Effect of Azacitidine (Aza C) on the Cytogenetically Tracked MDS Clone Impact Survival.

Pretreatment Cytogenetic Abnormalities in Polycythemia Vera (PV) Determines the Effectivnes of Imatinib : Studies from a Multi-Institutional Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only